Publication:
Retraction Note: TRIB2 confers resistance to anti-cancer therapy by activating the serine/threonine protein kinase AKT.

Thumbnail Image

Files

Retraction Note_TRIB2 confers resistance_Nat Commun_2023.pdf (165.02 KB)
Identifiers
URI: http://hdl.handle.net/20.500.12105/16396
DOI: 10.1038/s41467-023-40050-1

Publication date

2023-07-19

Authors

Advisors

Journal Title

Journal ISSN

Volume Title

Publishers

Nature Publishing Group
Metrics
Google Scholar
Export
MarcXML METS

Research Projects

Organizational Units

Journal Issue

Abstract

Description

Keywords

MeSH Terms

DeCS Terms

Bibliographic citation

Nat Commun. 2023 Jul 19;14(1):4341.

Collections

Grupos de investigación

Publisher version

10.1038/s41467-023-40050-1

Related dataset

Related publication

Document type

other